Repositorio Dspace

Listar por tema "Immunosuppressive Agents/therapeutic use"

Listar por tema "Immunosuppressive Agents/therapeutic use"

Ordenar por:Orden:Resultados:

  • Meca-Lallana, José; Ayuso, Teresa; Martínez-Yelamos, Sergio; Duran, Carmen; Contreras-Martín, Yessica; Herrera-Navarro, Nicolas; Pérez-Sempere, Ángel; Álvarez-Cermeno, José-C; Millán-Pascual, Jorge; Meca-Lallana, Virginia; Romero-Sevilla, Raul; Ricart, Javier (KARGER, 2020-05)
    BACKGROUND: There is a lack of head-to-head studies comparing the efficacy of fingolimod (FIN) and natalizumab (NTZ) as second-line therapy for relapsing-remitting multiple sclerosis (RRMS). METHODS: Multicenter, observational ...
  • López, Verónica; Vázquez, Teresa; Alonso-Titos, Juana; Cabello, Mercedes; Alonso, Ángel; Beneyto, Isabel; Crespo, Marta; Diaz-Corte, Carmen; Franco, Antonio; González-Roncero, Francisco; Gutiérrez, Elena; Guirado, Luis; Jiménez, Carlos; Jironda, Cristina; Lauzurica, Ricardo; Llorente, Santiago; Mazuecos, Auxiliadora; Paul, Javier; Rodríguez-Benot, Alberto; Carlos-Ruiz, Juan; Sánchez-Fructuoso, Ana; Sola, Eugenia; Torregrosa, Vicente; Zarraga, Sofia; Hernández, Domingo (SOC ESPANOLA NEFROLOGIA DR RAFAEL MATESANZ, 2020-05)
    The SARS-CoV-2 (Covid-19) coronavirus pandemic is evolving very quickly and means a special risk for both immunosuppressed and comorbid patients. Knowledge about this growing infection is also increasing although many ...
  • Barrero, Francisco; Mallada-Frechin, Javier; Martínez-Gines, María-Luisa; Eugenia-Marzo, María; Meca-Lallana, Virginia; Izquierdo, Guillermo; Ramon-Ara, José; Oreja-Guevare, Celia; Meca-Lallana, José; Forero, Lucia; Sánchez-Veram, Irene; Moreno, María-José (PUBLIC LIBRARY SCIENCE, 2020-04-02)
    PURPOSE: The objective of this study was to characterize the demographic and clinical profile of RRMS patients receiving fingolimod in Spain, and to evaluate drug effectiveness and safety in clinical practice. METHODS: ...